Procurement Summary
Country : Brazil
Summary : Regular Acquisition of Purchase of Medicines Belonging to Group 0936 (Registered Specific Purchase Medicines) and Group 09.99.10 (Standard Drugs. Protocol Power), Aiming to Meet ...
Deadline : 07 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 116843020
Document Ref. No. : 90076/2025
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Regular Purchase of Purchase of Medicines belonging to Group 0936 (specific purchase medicines) and Group 09.99.10 (Standard Medicines. Protocol Power), aiming to serve patients who filed a lawsuit, in price registration system, To meet the needs of the Health Secretariat DF, according to specifications and quantities contained in Annex I of the Notice.
UASG Code: 926119
Notice from: 26/03/2025 from 08:00 to 12:00 and from 14:00 to 17:00 HS
Delivery of the proposal: from 03/26/2025 to 08:00
Denosumab, Concentration 70 mg/ml, pharmaceutical form injectable solution
Quantity: 54
Denosumab, concentration 70 mg/ml, pharmaceutical form injectable solution
Quantity: 18
DeutetraBenazine, concentration 6 mg, additional prolonged release
Quantity: 1620
Deutetrabranazine, concentration 6 mg, additionalProlonged release
Quantity: 540
dupilumab, concentration 175 mg/ml, pharmaceutical form injectable solution, additional syringe filled
quantity: 216
dupilumab, concentration 175 mg/ml, pharmaceutical form injectable solution, additional syringe
quantity: 72
spiesolimab, concentration60 mg/ ml, concentrated pharmaceutical form for solutionp/ dilution for infusion
quantity: 54
spiesolimab, concentration 60 mg/ ml, concentrated pharmaceutical form for solutionp/ dilution for infusion
quantity: 18
estradiol, concentration 1 mg/ g, pharmaceutical form gel with dose bottle
quantity: quantity:2160
Evolocumab, concentration 140 mg/ ml, pharmaceutical form injectable solution, additional with applicator pen
Quantity: 162
Evolocumab, concentration 140 mg/ ml, pharmaceutical form injectable solution, additional with applicator pen
quantity:54
Documents
Tender Notice